The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be (link sends e-mail)
| Study Name on ClinicalTrials.gov (link is external) | Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years |
|---|---|
| Study Drug | Inhaled Mannitol (Bronchitol) |
| Type of Study Drug | Bronchodilator |
| Study Title | A Randomised, Multicentre, Double-blind, Placebo-controlled, Crossover Trial Determining the Efficacy of Dry Powder Mannitol in Improving Lung Function in Subjects With Cystic Fibrosis Aged Six to Seventeen Years |
| Study Phase | 2 |
| Study Sponsor | Pharmaxis |
http://www.clinicaltrials.gov/ct2/show/NCT01883531 (link is external) | |
| Participating ECFS-CTN sites | Belgium: Leuven France: Lyon, Reims, Paris (Debré), Montpellier Germany : Frankfurt Italy: Milan, Rome, Verona The Netherlands: Rotterdam UK: Birmingham, London, Nottingham |
| Age | 6 Years to 17 Years |